Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer
- 31 May 2008
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 109 (2), 263-269
- https://doi.org/10.1016/j.ygyno.2008.01.024
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Role of cytoreduction in stage III and IV uterine papillary serous carcinomaGynecologic Oncology, 2007
- Overexpression of Clostridium perfringens Enterotoxin Receptors Claudin-3 and Claudin-4 in Uterine CarcinosarcomasClinical Cancer Research, 2007
- Overexpression of claudin‐3 and claudin‐4 receptors in uterine serous papillary carcinomaCancer, 2007
- Expression pattern of adhesion molecules (E‐cadherin, α‐, β‐, γ‐catenin and claudin‐7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasisAPMIS, 2007
- Expression of claudin-3 and claudin-4 in normal, hyperplastic, and malignant endometrial tissueInternational Journal of Gynecologic Cancer, 2007
- Complex networks orchestrate epithelial–mesenchymal transitionsNature Reviews Molecular Cell Biology, 2006
- Claudin Proteins in Human Cancer: Promising New Targets for Diagnosis and TherapyCancer Research, 2005
- Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapyBritish Journal of Cancer, 2005
- Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breastOncogene, 2003
- Extended Surgical Staging for Uterine Papillary Serous Carcinoma: Survival Outcome of Locoregional (Stage I–III) DiseaseGynecologic Oncology, 2001